These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36345771)

  • 21. Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations.
    Wills JW; Johnson GE; Doak SH; Soeteman-Hernández LG; Slob W; White PA
    Mutagenesis; 2016 May; 31(3):255-63. PubMed ID: 26687511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A decision tree-based integrated testing strategy for tailor-made carcinogenicity evaluation of test substances using genotoxicity test results and chemical spaces.
    Fujita Y; Honda H; Yamane M; Morita T; Matsuda T; Morita O
    Mutagenesis; 2019 Mar; 34(1):101-109. PubMed ID: 30551173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
    Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical appraisal of the sensitivity of in vivo genotoxicity assays in detecting human carcinogens.
    Zeller A; Pfuhler S; Albertini S; Bringezu F; Czich A; Dietz Y; Fautz R; Hewitt NJ; Kirst A; Kasper P
    Mutagenesis; 2018 Apr; 33(2):179-193. PubMed ID: 29669112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical review of styrene genotoxicity focused on the mutagenicity/clastogenicity literature and using current organization of economic cooperation and development guidance.
    Moore MM; Pottenger LH; House-Knight T
    Environ Mol Mutagen; 2019 Aug; 60(7):624-663. PubMed ID: 30786062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
    Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
    Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view.
    Bergman K; Müller L; Teigen SW
    Mutat Res; 1996 Feb; 349(2):263-88. PubMed ID: 8600357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo genotoxicity testing strategies: Report from the 7th International workshop on genotoxicity testing (IWGT).
    Kirkland D; Uno Y; Luijten M; Beevers C; van Benthem J; Burlinson B; Dertinger S; Douglas GR; Hamada S; Horibata K; Lovell DP; Manjanatha M; Martus HJ; Mei N; Morita T; Ohyama W; Williams A
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403035. PubMed ID: 31699340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type.
    Fowler P; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
    Mutat Res; 2012 Feb; 742(1-2):11-25. PubMed ID: 22138618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting rodent carcinogenicity from mutagenic potency measured in the Ames Salmonella assay.
    Fetterman BA; Kim BS; Margolin BH; Schildcrout JS; Smith MG; Wagner SM; Zeiger E
    Environ Mol Mutagen; 1997; 29(3):312-22. PubMed ID: 9142175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro mammalian cell mutation assays based on transgenic reporters: A report of the International Workshop on Genotoxicity Testing (IWGT).
    White PA; Luijten M; Mishima M; Cox JA; Hanna JN; Maertens RM; Zwart EP
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403039. PubMed ID: 31699347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.